Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Quant Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesAster DM Healthcare Limited10.010467721540.9647
Domestic EquitiesRPG Life Sciences Limited8.831915052936.1420
Domestic EquitiesZydus Wellness Ltd6.364012834626.0427
Domestic EquitiesSequent Scientific Limited6.2074147712625.4021
Domestic EquitiesAlivus Life Sciences6.205924629825.3958
Domestic EquitiesPfizer Ltd6.08714795424.9097
Domestic EquitiesAurobindo Pharma Limited6.052421730024.7679
Domestic EquitiesANTHEM BIOSCIENCES LIMITED5.936332000024.2928
Domestic EquitiesHDFC Life Insurance Co Ltd5.490729740622.4690
Domestic EquitiesSMS Pharmaceuticals Limited4.770683321319.5222
Domestic EquitiesHFCL Limited4.4135239000018.0612
Domestic EquitiesMax Healthcare Institute Limited4.304814138117.6161
Domestic EquitiesSun Pharmaceutical Industries Limited3.22177724913.1841
Domestic EquitiesLaxmi Dental Limited2.991829009112.2433
Domestic EquitiesLupin Limited2.68595697610.9912
Total 83.5744 342.0048
Cash & Cash Equivalents and Net AssetsTREPS 01-Aug-2025 DEPO 1011.42484675346.7528
Cash & Cash Equivalents and Net AssetsNCA-NET CURRENT ASSETS-15.3566 -62.8425
Total -3.9318 -16.0897
Treasury Bills91 Days Treasury Bill 21-Aug-20251.21835000004.9855
Treasury Bills91 Days Treasury Bill 18-Sep-20250.97074000003.9723
Treasury Bills91 Days Treasury Bill 28-Aug-20250.73023000002.9883
Treasury Bills91 Days Treasury Bill 25-Sep-20250.72733000002.9761
Treasury Bills91 Days Treasury Bill 11-Sep-20250.48582000001.9881
Treasury Bills182 Days Treasury Bill 04-Sep-20250.24321000000.9951
Treasury Bills91 Days Treasury Bill 04-Sep-20250.24321000000.9951
Total 4.6186 18.9005
Derivatives-FuturesLupin Limited 28/08/20256.210013132525.4127
Derivatives-FuturesSun Pharmaceutical Industries Limited 28/08/20253.04907280012.4772
Derivatives-FuturesAurobindo Pharma Limited 28/08/20252.61829350010.7142
Derivatives-FuturesDr. Reddy's Laboratories Limited 28/08/22.49128000010.1944
Derivatives-FuturesBiocon Ltd 28/08/20251.37041425005.6081
Total 15.7388 64.4066
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.